Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Basel Medical (BMGL) Liabilities and Shareholders Equity: 2024-2025

Historic Liabilities and Shareholders Equity for Basel Medical (BMGL) over the last 2 years, with Q2 2025 value amounting to $13.3 million.

  • Basel Medical's Liabilities and Shareholders Equity rose 993.39% to $13.3 million in Q2 2025 from the same period last year, while for Jun 2025 it was $25.3 million, marking a year-over-year change of. This contributed to the annual value of $13.3 million for FY2025, which is 952.9% up from last year.
  • Latest data reveals that Basel Medical reported Liabilities and Shareholders Equity of $13.3 million as of Q2 2025, which was up 993.39% from $12.1 million recorded in Q2 2024.
  • In the past 5 years, Basel Medical's Liabilities and Shareholders Equity ranged from a high of $13.3 million in Q2 2025 and a low of $12.1 million during Q2 2024